40 mg/day vormatrogine for 12 weeks
PRAX-628-322
Phase 3 small_molecule active
Quick answer
40 mg/day vormatrogine for 12 weeks for Focal Epilepsy is a Phase 3 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PRECISION BIOSCIENCES INC
- Indication
- Focal Epilepsy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active